title: Early clinical experience with the use of the Birmingham hip resurfacing system.
abstract: This study reviews the early clinical experience with the Birmingham Hip resurfacing system (Smith & Nephew, Memphis, Tenn) in the United States since its approval by the FDA. A total of 230 patients were followed for a mean of 16 months (range, 6 months). There was a significant improvement in the mean preoperative Oxford hip score at the latest follow-up (44 points [range, 30-58 points] to 17 points [range, 12-28 points]). The most commonly used femoral component was 50 mm, and the mean duration of the procedures was 95 minutes (range, 65-180 min). there were 3 revisions (1.3%). Early results are favorable. As with any device, there is a continuing need for longterm monitoring and large-scale epidemiologic surveillance.
authors.affiliation: Departmetn of Orthopaedics and Sports Medicine, University of South Florida, 3500 East Fletcher Avenue, Suite 511, MDC106, Tampa, FL 33613, USA.
authors.forename: German A
authors.initials: GA
authors.lastname: Marulanda
authors.forename: M Stephen
authors.initials: MS
authors.lastname: Wilson
authors.forename: Paul
authors.initials: P
authors.lastname: Edwards
authors.forename: Steve
authors.initials: S
authors.lastname: Raterman
mesh_terms: D000328:Adult; D000368:Aged; D019644:Arthroplasty, Replacement, Hip / Q000295:instrumentation* / Q000379:methods*; D019544:Equipment Failure Analysis; D005260:Female; D006621:Hip Joint / Q000601:surgery*; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D010865:Pilot Projects; D011474:Prosthesis Design; D020127:Recovery of Function; D016896:Treatment Outcome